HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patients.

International journal of oncology

Volumn 24, Issue 4, 2004, Pages 967-975

  Ishihara, Yuki ^a   Harada, Mamoru ^a   Azuma, Koichi ^a   Tamura, Mayumi ^a   Shomura, Hiroki ^a   Fujii, Teruhiko ^a   Itoh, Kyogo ^a   Shichijo, Shigeki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; OLIGOPEPTIDE;

ANTIBODY PRODUCTION; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETIC TRANSFECTION; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; MALE; NEOPLASM;

ANTIBODY FORMATION; FEMALE; HLA-A2 ANTIGEN; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MALE; NEOPLASMS; OLIGOPEPTIDES; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 1842841684     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.24.4.967     Document Type: Article

References (0)